论文部分内容阅读
目的 探讨玻璃体切除术治疗糖尿病性视网膜病变后单纯性玻璃体积血的临床疗效。方法 回顾性分析 1 998年 8月～ 2 0 0 0年 1 0月我院采用玻璃体切除方法治疗糖尿病性视网膜病变单纯玻璃体积血患者 40例 (40眼 ) ,观察其临床疗效及术后并发症 ,随访期术后 3～ 1 2月。结果 所有患者均顺利完成玻璃体积血切割术 ,术后 3月视力≥ 0 6者 1 0眼 ,视力 0 1～0 6者 2 0眼 ,视力数指～0 1者 5眼 ,3眼术后发生视网膜脱离视力下降 ,2眼术后发生新生血管性青光眼 ,后行睫状体冷凝术视力丧失。结论 玻璃体切除术对于糖尿病性增生性视网膜病变所致的玻璃体积血性药物治疗长期不吸收的患者是安全有效的治疗方法 ,术后并发症少 ,手术效果好
Objective To investigate the clinical effect of vitrectomy on simple vitreous hemorrhage after diabetic retinopathy. Methods Retrospective analysis of 40 cases (40 eyes) of vitreous hemorrhage patients with diabetic retinopathy treated by vitrectomy in our hospital from August 1998 to January 2010, the clinical efficacy and postoperative complications were observed The follow-up period was from 3 to 12 months. Results All patients successfully completed vitreous hemorrhage. There were 10 eyes with ≥ 0.6 in 3 months, 20 eyes with 0 1 ~ 0 6 eyes, 5 eyes with ~ 0 1 eyesight, 3 eyes after operation Ocular retinal detachment decreased visual acuity, 2 cases of neovascular glaucoma occurred after surgery, ciliary body condensation after vision loss. Conclusions Vitrectomy is a safe and effective treatment for patients with long-term non-absorption of vitreous hemorrhage caused by diabetic proliferative retinopathy. There are few postoperative complications and good operative effects